logo

OCGN

Ocugen·NASDAQ
--
--(--)
--
--(--)
2.12 / 10
Underperform

OCGN's fundamentals are underperforming: key ratios like Interest Coverage (15.48) and Profit-MV (0.46) are offset by concerning factors such as Days Sales Outstanding (72.55) and PB-ROE (7.12). The negative margins and high collection period signal operational inefficiencies, warranting caution despite some positive YoY revenue growth (39.96%).

Fundamental(2.12)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-3.75
Score1/3
Weight11.37%
1M Return4.24%
Total operating revenue (YoY growth rate %)
Value39.96
Score2/3
Weight2.42%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-3.11%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight22.58%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight22.61%
1M Return8.45%
PB-ROE
Value7.12
Score0/3
Weight6.74%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-2.26%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value39.96
Score2/3
Weight0.93%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight16.52%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight22.20%
1M Return8.41%
Is OCGN undervalued or overvalued?
  • OCGN scores 2.12/10 on fundamentals and holds a Premium valuation at present. Backed by its -302.37% ROE, -1192.18% net margin, -7.65 P/E ratio, 123.22 P/B ratio, and -24.75% earnings growth, these metrics solidify its Underperform investment rating.